Investigation of Mechanosensory Signaling in the Pathogenesis of Traumatic Brain Injury in Human iPSC-derived Cortical Brain Organoids

人 iPSC 衍生的皮质脑类器官中机械感觉信号传导在创伤性脑损伤发病机制中的研究

• 批准号: 10548870
• 负责人: Joshua Berlind
• 金额: $ 4.23万
• 依托单位: UNIVERSITY OF SOUTHERN CALIFORNIA
• 依托单位国家: 美国
• 财政年份: 2021
• 资助国家: 美国
• 起止时间: 2021-01-15 至 2023-04-24
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10548870
• 关键词: 3-Dimensional; 5' -AMP-activated protein kinase; Acute; Animal Model; Animals; Antisense Oligonucleotides; Anxiety; Astrocytes; Autopsy; Biochemical; Biology; Biophysical Process; Blood; Brain; Case Study; Cations; Cell Line; Cells; Chemicals; Chronic; Clinical; Complex; Data; Dementia; Diffuse Axonal Injury; Disease; Edema; Elderly; Environmental Risk Factor; Etiology; Event; Focused Ultrasound Therapy; Frontotemporal Dementia; Functional disorder; Gene Expression; General Population; Genetic; Genetic Transcription; Goals; Human; Immunoassay; Immunologic Factors; In Vitro; Incidence; Individual; Inflammation; Injury; Investigation; Measures; Mechanics; Mental Depression; Metabolic dysfunction; Military Personnel; Modeling; Molecular; Mus; Mutation; Nerve Degeneration; Neurodegenerative Disorders; Neuronal Injury; Neurons; Organoids; Outcome; Pathogenesis; Pathologic; Pathology; Patients; Phenotype; Phosphotransferases; Process; Risk; Role; Sampling; Signal Transduction; Survival Rate; Symptoms; System; TBI Patients; TDP-43 aggregation; Testing; Time; Tissue Model; Transgenic Mice; Trauma; Traumatic Brain Injury; Ultrasonics; United States; Western Blotting; Work; axon injury; blood-brain barrier disruption; cell injury; cell type; controlled cortical impact; dementia risk; disability; disease-causing mutation; hyperphosphorylated tau; improved; in vivo; in vivo Model; induced pluripotent stem cell; injured; innovation; insight; knock-down; mechanotransduction; mortality; mouse model; nerve stem cell; neuron loss; neuronal survival; neuroprotection; new therapeutic target; novel; preservation; pressure; prevent; programs; protein TDP-43; response; severe injury; tau Proteins; tau aggregation; tau-1; therapeutic target; transcriptome sequencing; transcriptomics

Project Summary/Abstract Global incidence of Traumatic Brain Injury (TBI) is on the rise, particularly among athletes, military personnel, and elderly citizens1. TBI represents a spectrum of mild to severe injuries that share many long-term pathologies and clinical symptoms such as Tau and TDP43 pathology, axonal injury, neuronal death, and increased risk of depression and neurodegenerative diseases2-6. Although end-stage pathologies are well characterized from post-mortem samples, the molecular mechanisms contributing to injury remain poorly understood in part due to the difficulty of studying live brains in human patients and the variable biophysical processes that occur between patients. As a result, available treatment options remain limited and are largely ineffective61. Previous studies of TBI conducted in animal models present with edema, inflammation, and blood-brain barrier disruption following an induced trauma6,7. Although important to the pathophysiology of TBI, this complex cascade of events complicates our ability to accurately understand cell autonomous injury mechanisms. Therefore, a reductionist system to study the response of distinct cell types to TBI would be beneficial for identifying and targeting changes that occur post-injury. To this end, we will utilize a 3-D cortical organoid culture system grown from human induced Pluripotent Stem Cells (iPSCs) to elucidate cell autonomous mechanisms of injury and degeneration caused by TBI8. We have developed a unique system of focused ultrasonic injury to mimic TBI in vitro which recapitulates key pathologic and transcriptional features of in vivo models. This allows for detailed study of both acute and chronic changes following an induced trauma, and provides a platform to integrate environmental and genetic contributions to injury while preserving human-specific biology. Using this system, we will combine bulk RNA-seq transcriptomic analysis with biochemical and immunoassays to uncover novel cell-type specific injury mechanisms. Using iPSC lines from patients with neurodegenerative diseases, we will test how TBI modulates genetically-induced disease mechanisms. Finally, we will test a mouse model of cortical controlled impact (CCI) to validate our findings in vivo. This proposal will greatly enhance our understanding of specific injury mechanisms in discrete cell types and may help to identify novel neuroprotective therapeutic targets.

项目总结/文摘